CCND1 and triple-negative breast carcinoma: Moreover, ATP citrate lyase (ACLY), a key enzyme responsible for de novo fatty acid synthesis, was considered to enhance triple-negative breast cancer (TNBC) stemness and metastasis via miR-206/ITGA2/ACLY-CCND1 signaling axis [25].